TEVA Pharmaceutical Industries LTD (TEVA)
- Sector
- Pharmaceuticals
- Last price
- $42.62
- As of
Kresmion compiles this page from TEVA's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 10-Q filed 2026-11-03.
See the full TEVA dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for TEVA on one page. Preview it with sample data, then open it live with a free account.
Preview the TEVA dossierActive events for TEVA
- mediumEarnings above estimates
Q3-2026: Beat consensus by 15.5%, EPS $0.86 vs $0.7446 estimate
- high13F: large reduction
CITADEL ADVISORS LLC cut 97% of TEVA (2026Q2)
- high13F: large reduction
Point72 Asset Management, L.P. cut 73% of TEVA (2026Q2)
- high13F: large increase
Point72 Asset Management, L.P. added +176% to TEVA (2026Q2)
- high13F: large increase
MILLENNIUM MANAGEMENT LLC added +4249% to TEVA (2026Q2)
FREE, NO ACCOUNT
Every event on TEVA, as it fires
You are seeing 5 of 13 events recorded on TEVA since 2026-05-30.
The five above landed across 2 days. The other 8 were recorded on 2 other days. 8 of the 13 are institutional flow rows, which arrive in batches on filing days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
No non-option holdings from tracked managers in this reporting quarter. Other reporting quarters are linked above.
Recent SEC filings, TEVA
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
More data on TEVA
- TEVA share buybacks Cash paid for repurchases, shares bought and program authorizations, from SEC filings.
- TEVA insider trading clusters Three or more insiders filing the same direction within 30 days, from SEC Form 4.
- TEVA against its peers Growth, margins and valuation beside the industry median, from annual SEC filings.
TEVA against its peers
TEVA's operating margin of 12.5% ranks in the 50th percentile of 16 Pharmaceuticals sub-industry peers, fiscal periods ending between 2025-12-28 and 2025-12-31.
| Metric | TEVA | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 17.3B USD | 5.2B USD | 67 | 22 |
| Gross margin | 51.8% | 74.3% | 16 | 15 |
| Operating margin | 12.5% | 10.6% | 50 | 16 |
| Net margin | 8.2% | 12.4% | 44 | 23 |
| Return on equity | 17.8% | 15.4% | 52 | 23 |
| P / E | 35.2x | 20.6x | 73 | 12 |
| 1 year | 75.3% | 21.8% | 75 | 25 |
Peers (25): ZTS, GSK, VTRS, BMY, JAZZ, PFE, NVO, AZN, NVS, CORT, AXSM, AMRX, MRK, LQDA, AMLX, TARS, OGN, JNJ, BHC, XERS, HRMY, TRVI, LLY, SUPN, ANIP. Fiscal periods ending between 2025-12-28 and 2025-12-31. Every figure is one full fiscal year read from one annual filing (TEVA: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Cite this data
Kresmion counts the managers it follows that reported a non-option position in TEVA on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on TEVA in the last 180 days.
Upstream: SEC EDGAR filings for TEVA
Kresmion, "TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) institutional holdings and SEC filings", data as of 2026-11-06, https://kresmion.com/research/TEVA. Upstream data: SEC EDGAR filings for TEVA.
Link to this data (HTML):
<a href="https://kresmion.com/research/TEVA">TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) institutional holdings and SEC filings (Kresmion)</a>
Writing about this? Press contact and ready-to-quote figures
Follow TEVA on a live board
Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to TEVA for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.